Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer.

CONCLUSIONS: The OS of TAM-treated patients with MBC was similar to the OS of TAM-treated FBC patients, whereas AI treatment is associated with poorer survival of MBC patients.
PMID: 29098396 [PubMed - as supplied by publisher]

Source: Clin Med Res - November 2, 2017 Category: Research Authors: Eggemann H, Altmann U, Costa SD, Ignatov A Tags: J Cancer Res Clin Oncol Source Type: research